Theodore R. Schroeder - Dec 31, 2021 Form 4 Insider Report for Nabriva Therapeutics plc (NBRV)

Role
Chief Executive Officer, Director
Signature
/s/ J. Christopher Naftzger, by power of attorney
Stock symbol
NBRV
Transactions as of
Dec 31, 2021
Transactions value $
-$64
Form type
4
Date filed
1/4/2022, 04:06 PM
Previous filing
Dec 29, 2021
Next filing
Jan 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBRV Ordinary Shares Tax liability -$64 -107 -0.03% $0.60 326K Dec 31, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.